期刊文献+

吡那地尔、美托洛尔、谷氨酰胺、胰岛素单独及联合使用对H9c2心肌细胞缺氧/复氧损伤的抗凋亡作用及机制 被引量:3

Antiapoptotic effects and mechanism of pinacidil,metoprolol, glutamine,insulin single and combination on H9c2 cardiac myocytes exposed to simulated hypoxia/reoxygenation
下载PDF
导出
摘要 目的研究吡那地尔(pinacidil,Pin)、美托洛尔(metoprolol,Met)、谷氨酰胺(glutamine,Glu)、胰岛素(insu-lin,Ins)4药联用对缺氧/复氧(hypoxia/reoxygenation,H/R)所致H9c2心肌细胞损伤的抗凋亡保护作用并探讨其作用机制。方法将培养的H9c2心肌细胞随机分为7组,即①正常对照(Con)组;②缺氧/复氧(H/R)组;③吡那地尔(Pin)组;④美托洛尔(Met)组;⑤谷氨酰胺(Glu)组;⑥胰岛素(Ins)组;⑦吡那地尔、美托洛尔、谷氨酰胺和胰岛素4药联用(PMGI)组。细胞经药物处理建立H/R损伤模型,并测定各组H9c2心肌细胞的存活率;收集培养液测定乳酸脱氢酶(lactate dehydrogenase,LDH)活性;流式细胞仪检测心肌细胞凋亡百分率;罗丹明123(Rhodamine123,Rh123)荧光探针标记线粒体,检测荧光强度以反映心肌细胞线粒体膜电位(mitochondrial membrane potential,△Ψm)变化。结果对于H/R损伤的H9c2心肌细胞,吡那地尔、美托洛尔、谷氨酰胺与胰岛素4药联用组与药物单用组或H/R组相比能明显提高细胞存活率,保护其细胞膜,减少LDH渗漏;减少细胞凋亡率;提高△Ψm。结论吡那地尔、美托洛尔、谷氨酰胺和胰岛素4药联用后,通过不同途径保护心肌细胞,达到协同抗凋亡作用。 Aim To investigate protective effects and mechanism of pinacidil,metoprolol,glutamine,insulin on H9c2 cardiac myocytes exposed to simulated hypoxia/reoxygenation.Methods H9c2 cardiac myocytes were randomly divided into seven groups:① Control group;② Hypoxia/reoxygenation(H/R) group;③ Pinacidil(Pin) group;④ Metoprolol(Met) group;⑤ Glutamine(Glu) group;⑥ Insulin(Ins) group;⑦ Pinacidil+Metoprolol+Glutamine+Insulin(PMGI) group.The survival rates of cardiomyocytes were detected.The activity of lactate dehydrogenase(LDH) in the culture medium was measured.The mitochondria were labeled by Rhodamine123 fluorescence probe and the fluorescent intensity produced by Rh123 was measured,which reflected changes of mitochondrial membrane potential(MMP,△Ψm).The apoptotic percentage was measured with flow cytometry.Results The combined use of pinacidil,metoprolol,glutamine,and insulin could protect the H9c2 cardiac cell membrane caused by hypoxia/reoxygenation injury,increase cell survival rate,decrease LDH leakage,decrease the apoptotic rate and increase the mitochondrial membrane potential.Conclusions Compared to the individual drug,the combination of the different mechanisms protects the mitochondria of cardiac myocyte,decreases the injury and enhances antiapoptotic effection of myocardial cells.
出处 《中国药理学通报》 CAS CSCD 北大核心 2011年第12期1723-1727,共5页 Chinese Pharmacological Bulletin
基金 高等学校博士学科点专项科研基金(No 20070062009)
关键词 缺氧/复氧损伤 联合用药 心肌细胞存活率 乳酸脱氢酶 细胞凋亡率 线粒体膜电位 hypoxia/reoxygenation drug combination survival rate of cardiomyocytes lactate dehydrogenase apoptotic percentage mitochondrial membrane potential
  • 相关文献

参考文献5

二级参考文献54

  • 1娄建石,张海波,刘艳霞,朱险峰,张才丽.无创性心功能血流动力学计算机实时监测系统[J].中国药理学通报,1996,12(1):91-95. 被引量:8
  • 2Fen Wei Wang, Abdulfatah Osman, Javier Otero, et al. Distal myocardial protection during percutaneous coronary intervention with an intracoronary-Blocker. Circulation, 2003, 107: 2914-2919.
  • 3T. B. Ferguson Jr, L P. Coombs, E.D. Peterson. Preoperative - blocker Use and mortality and morbidity following CABG surgery in north America. JAMA, 2002, 287(17) :2221-2226.
  • 4Mihai Gheorghimte, Sidney GoldsteirL Blockers in the Post-Myocardial Infarction Patient. Circulation, 2002,106:394 - 398.
  • 5Sharma SK, Kini A, Marmur JD, et aL Cardioprotective effect of prior-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention: benefit is extended to improvement in intermediate-term survival. Circulation, 2000, 102: 166-172.
  • 6Stephen G. Ellis, Sorin J. Brener, A. Michael Lincoff, et aL Blockers before percutancous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise. Circulation, 2001, 104 : 2685 -2688.
  • 7Wang S,Kotamraju S,Konorev E,et al.Activation of nuclear factor κB during doxorubiocin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic:the role of hydrogen peroxide[J].Biochem J,2002,367:729-740.
  • 8Chandrasekar B,Freeman GL.Induction of nuclear factor-κB and activation protein-1 in postischemic myocardium[J].FEBS Lett,1997,401:30-34.
  • 9Zingarelli B,Hake PW,Denenbery A,et al.Sesquiterpene Lactone Parthenolide.an inhibitor of IkappaB kinase complex and nuclear factor-KappaB,exerts beneficial effects in myocardial reperfusion injury[J].Shock,2002,17(2):127-134.
  • 10Gruo V,Yan Z,Hansson G,et al.Nuclear factor Kappa-B and the heart[J]J Ameri Col Cardio,2001,38(2):307-314.

共引文献28

同被引文献27

  • 1张丽志,苏健,温克.1-磷酸鞘氨醇对过氧化氢所致微血管通透性增高的影响[J].中国现代应用药学,2013,30(1):6-9. 被引量:5
  • 2赵慧娟,龙明智.心肌缺血再灌注损伤机制的研究近况[J].中西医结合心脑血管病杂志,2005,3(3):240-242. 被引量:12
  • 3赵祯,安冬艳,秦丽娟,曹宇.HSP70在经热应激预处理后减少大鼠肝脏缺血再灌注损伤过程中的作用[J].中国药理学通报,2005,21(4):454-457. 被引量:10
  • 4Murphy E,Steenbergen C.Mechanisms underlying acute pro-tection from cardiac ischemia-reperfusion injury[J].PhysiolRev,2008,88(2):581-609.
  • 5Lochner A,Marais E,Genade S,et al.Protection of the is-chemic heart:investigations into the phenomenon of ischaemicpreconditioning[J].Cardiovasc J Afr,2009,20(1):43-51.
  • 6Wakeno-Takahashi M,Otani H,Nakao S,et al.Adenosineand a nitric oxide donor enhances cardioprotection by precondi-tioning with isoflurane through mitochondrial adenosinetriphosphate-sensitive K+ channel-dependent and-independentmechanisms[J].Anesthesiology,2004,100(3):515-524.
  • 7Lynch JJ Jr,Salata JJ,Wallace AA,etaL.Antiarrhythmic ef-ficacy of combined I(Ks)and beta-adrenergic receptor blockade[J].J Pharmacol Exp Ther,2002,302(l):283-289.
  • 8Gao F,Yao CL,Gao E,et al.Enhancement of glutathionecardioprotection by ascorbic acid in myocardial reperfusion in-jury[J].J Pharmacol Exp Ther,2002,301(2):543-550.
  • 9Ruiz-Gines JA? Lopez-Ongil S,Gonzdlez-Rubio M,et al.Re-active oxygen species induce proliferation of bovine aortic endo-thelial cells[J].J Cardiovasc Pharmacol,2000,35 C I):109-113.
  • 10Yellon DM,Hausenloy DJ.Myocardial reperfusion injury[J].N Engl J Med,2007,357(11):1121-1135.

引证文献3

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部